why UNS sp in ASX today?, page-30

First 30 Last

Share
Profile

Follow
ChristopherC

4,961 Posts.

541

29/07/16

20:15

Post #: 18403881
Share

Originally posted by ChristopherC ↑

I think it may have something to do with market conditions where the US investors took a more positive view on the announcement, and their market is extremely positive at present, whilst the aussies are more cautious and market here is muddling along.
When i initially read the announcements i was relieved but also angry and a little bit negative. Have now had time to digest and feel a little bit more positive now.
My main concern is that statements about focus and direction, have been made without full details of what was the companies previous focus and how the change in focus has affected this side of the business. Are all the years of work and development for zilch, cant they communicate what is happening with PFS? Surely they aren't abandoning it completely? Who knows from todays announcements.
Orbimed and Amgen still on board otherwise Amgen wouldn't have changed the terms relating to convertables, gives brething space to sort NASDAQ listing. Would love an update on all contracts and customers and where we are at production wise.
One hugh positive is AS now completely gone and not costing us coin. Always thought there was something a little dodgy going on behind the scenes.
So maybe we will see no sell off in US. Will stay up tonight and watch for a couple of hours, before hitting the hay as have to work tomorrow.

Christopher ( getting the caffeine into the bloodstream )

Expand

Also with investigation completed, will soon report as required and may do a long awaited earnings call ( one can always hope ).

UNS Price at posting: 8.4¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 10 more messages in this thread...

First 30 Last

Add UNS (ASX) to my watchlist

why UNS sp in ASX today?, page-30

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News